Riskpilot← Back to searchSign inGet full accessKOSMED AS
ASActiveOrg 915509673Torget 1, 3256 LarvikMedical specialists activities · NACE 8622Est. 20152 employeeswww.kosmed.no
Revenue 2024
NOK 4,3M
+34% vs 2023
EBITDA margin
17.1%
+180% vs 2023
Equity ratio
60.6%
Financial strength
Net profit 2024
NOK 468K
+200% vs 2023
| Revenue | NOK 4,3M | +34% |
| EBITDA | NOK 735K | +180% |
| Net profit | NOK 468K | +200% |
| Total assets | NOK 1,7M | +41% |
| Equity | NOK 1M | +82% |
| Employees | 2 | — |
Legal name
KOSMED AS
Org number
915509673
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
15. juni 2015
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Tilby medisinske og kirurgiske behandlinger til privatpersoner. Salg av tjenester og behandling av pasienter med behandlingsmaskiner for legeindustrien. Kjøp og salg av relevante produkter.
Address
Torget 1, 3256 Larvik
Website
www.kosmed.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 498 | 1 161 | 1 383 | 1 845 | 2 249 | 2 769 | 2 792 | 2 451 | 3 197 | 4 284 |
| Staff expenses | −5 | −302 | −365 | −103 | −112 | −785 | −993 | −1 167 | −1 281 | −1 532 |
| EBITDA | 169 | 32 | −27 | 189 | 331 | 376 | 319 | 2 | 262 | 735 |
| Depreciation & amort. | −153 | −125 | −178 | −121 | −68 | −55 | −44 | −47 | −61 | −127 |
| EBIT | 17 | −93 | −205 | 67 | 262 | 322 | 275 | −45 | 201 | 608 |
| Net financials | −11 | −14 | −19 | −21 | −41 | −20 | −5 | −2 | −10 | −6 |
| Profit before tax | 6 | −107 | −224 | 46 | 222 | 302 | 270 | −47 | 191 | 601 |
| Tax | 2 | −0 | −0 | −0 | −0 | 25 | 61 | −3 | 35 | 134 |
| Net profit | 4 | −107 | −224 | 46 | 222 | 277 | 209 | −45 | 156 | 468 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 907 | 763 | 1 049 | 830 | 824 | 797 | 836 | 1 018 | 1 214 | 1 709 |
| Equity | 34 | −73 | −297 | −250 | −29 | 248 | 458 | 413 | 568 | 1 036 |
| Long-term debt | 0 | 0 | 0 | 924 | 685 | 340 | 3 | 285 | 133 | 27 |
| Short-term debt | 873 | 836 | 1 346 | 156 | 167 | 208 | 376 | 321 | 513 | 646 |
| Total debt | 873 | 836 | 1 346 | 1 080 | 853 | 548 | 379 | 606 | 646 | 673 |
EBITDA margin
17.1%
This company
15.8%
Market median
+8% vs market
20152024
Equity ratio
60.6%
This company
38.2%
Market median
+59% vs market
20152024
Return on equity
45.1%
This company
18.4%
Market median
+145% vs market
20152024
Net profit margin
10.9%
This company
8.1%
Market median
+35% vs market
20152024
Asset turnover
2.51×
This company
1.12×
Market median
+124% vs market
20152024
Debt / equity
0.65×
This company
0.62×
Market median
+5% vs market
20152024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MS Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KOSMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marthe Sommereng | Chief Executive Officer | 0 companies |
| Anders Nygaard Larsen | Board of Directors | 0 companies |
| Ragne Ulnes Sætre | Chairman | 0 companies |